Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Endocyte Inc.
DescriptionFolate-conjugated form of rapamycin inhibitor
Molecular Target Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)
Mechanism of ActionMammalian target of rapamycin (mTOR) kinase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPolycystic kidney disease (PKD)
Indication DetailsTreat polycystic kidney disease (PKD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today